VVUS

VIVUS, Inc. News Headlines

$4.31
*  
0.02
0.47%
Get VVUS Alerts
*Delayed - data as of Sep. 2, 2014 12:40 ET  -  Find a broker to begin trading VVUS now
Exchange: NASDAQ
Industry: Health Care
Community Rating:
View:    VVUS Real Time
 
 
Symbol List Views
FlashQuotes InfoQuotes
Stock Details
Summary Quote Real-Time Quote After Hours Quote Pre-market Quote Historical Quote Option Chain
CHARTS
Basic Chart Interactive Chart
COMPANY NEWS
Company Headlines Press Releases Market Stream
STOCK ANALYSIS
Analyst Research Guru Analysis Stock Report Competitors Stock Consultant Stock Comparison
FUNDAMENTALS
Call Transcripts Annual Report Income Statement Revenue/EPS SEC Filings Short Interest Dividend History
HOLDINGS
Ownership Summary Institutional Holdings Insiders
(SEC Form 4)
 Save stocks for next time
Viewing
Filtered By
Ordered By

3 Simple Ways to Invest Like George Soros
8/30/2014 11:42:02 AM - Motley Fool

Belviq Sales Crack Critical Level
8/29/2014 4:46:00 PM - Seeking Alpha

VIVUS Acquires Certain Topamax Related Patents from J&J - Analyst Blog
8/26/2014 5:00:00 PM - Zacks.com

ADXS Makes It Big, ALKS Waiting To Face FDA, ITMN Snapped Up, KITE Flies High
8/26/2014 12:52:00 AM - RTT News

Vivus Acquires Patent Rights To Qsymia Ingredient
8/25/2014 1:38:00 PM - Seeking Alpha

Advertising And The Belviq Re-Launch
8/25/2014 1:29:00 PM - Seeking Alpha

Belviq Sales Rise 2%
8/25/2014 9:57:00 AM - Seeking Alpha

VIVUS Announces Acquisition Of Group Of Patents From Janssen Pharma
8/25/2014 7:09:00 AM - RTT News

Biotech Investing: 3 Ways You're Doing It Wrong
8/24/2014 2:35:02 PM - Motley Fool

Arena And VIVUS: A Case Study In Small-Cap Pharma
8/18/2014 7:53:00 AM - Seeking Alpha

2nd Half Of 2014 Biotechnology Catalysts--Part 4
8/17/2014 8:28:00 PM - Seeking Alpha

Belviq Sales Flatten Out But Edge Above Qsymia
8/15/2014 4:10:00 PM - Seeking Alpha

FDA Data: Good News For One Anti-Obesity Company, Not So Good For Another
8/15/2014 9:15:00 AM - Seeking Alpha

Auxilium Posts Wider-than-Expected Loss, Outlook Maintained - Analyst Blog
8/12/2014 2:10:00 PM - Zacks.com

Arena's Belviq Bucks Seasonality With 3.6% Week Over Week Gain
8/8/2014 1:28:00 PM - Seeking Alpha

VIVUS Reports Narrower-than-Expected Loss on Qsymia Sales - Analyst Blog
8/8/2014 11:00:00 AM - Zacks.com

Vivus Beats The Street - Still Has A Loss
8/8/2014 10:04:00 AM - Seeking Alpha

Orexigen Therapeutics Reports Wider Q2 Loss as Costs Mount - Analyst Blog
8/8/2014 9:20:00 AM - Zacks.com

Orexigen Hits Expectations But That Is Not The Big News
8/7/2014 1:25:00 PM - Seeking Alpha

Will Emergent BioSolutions (EBS) Earnings Disappoint in Q2? - Analyst Blog
8/6/2014 5:45:00 PM - Zacks.com

Will Horizon Pharma (HZNP) Earnings Miss Estimates in Q2? - Analyst Blog
8/6/2014 5:00:00 PM - Zacks.com

Will Mylan (MYL) Earnings in Q2 Disappoint Expectations? - Analyst Blog
8/6/2014 4:35:00 PM - Zacks.com

2nd Half Of 2014 Biotechnology Catalysts-Part 3
8/4/2014 2:36:00 PM - Seeking Alpha

Arena Pharmaceuticals Falls on Wider-than-Expected Q2 Loss - Analyst Blog
8/4/2014 11:10:00 AM - Zacks.com

Possible Delay In Orexigen Approval Process In Europe
7/31/2014 9:54:00 AM - Seeking Alpha